nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0843	0.0843	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0717	0.0717	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0712	0.0712	CbGpPWpGaD
Levofloxacin—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0494	0.0494	CbGpPWpGaD
Levofloxacin—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.0422	0.0422	CbGpPWpGaD
Levofloxacin—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0372	0.0372	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0316	0.0316	CbGpPWpGaD
Levofloxacin—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.0293	0.0293	CbGpPWpGaD
Levofloxacin—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.0262	0.0262	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0251	0.0251	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0242	0.0242	CbGpPWpGaD
Levofloxacin—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0189	0.0189	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0179	0.0179	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0176	0.0176	CbGpPWpGaD
Levofloxacin—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0163	0.0163	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0161	0.0161	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0153	0.0153	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.015	0.015	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0149	0.0149	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0137	0.0137	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0135	0.0135	CbGpPWpGaD
Levofloxacin—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0126	0.0126	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.0119	0.0119	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.0119	0.0119	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.0115	0.0115	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0115	0.0115	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.0112	0.0112	CbGpPWpGaD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0111	0.0111	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.011	0.011	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.0107	0.0107	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.0104	0.0104	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00912	0.00912	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00901	0.00901	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.009	0.009	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0087	0.0087	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00775	0.00775	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0076	0.0076	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00725	0.00725	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0072	0.0072	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0069	0.0069	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00642	0.00642	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00624	0.00624	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00594	0.00594	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00559	0.00559	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00552	0.00552	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00546	0.00546	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00542	0.00542	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0052	0.0052	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00502	0.00502	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00492	0.00492	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00459	0.00459	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00418	0.00418	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00415	0.00415	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00415	0.00415	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00403	0.00403	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00396	0.00396	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00387	0.00387	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00387	0.00387	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00331	0.00331	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00331	0.00331	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00317	0.00317	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00296	0.00296	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00269	0.00269	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00267	0.00267	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00265	0.00265	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00264	0.00264	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00252	0.00252	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00207	0.00207	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00206	0.00206	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00204	0.00204	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00195	0.00195	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00171	0.00171	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00159	0.00159	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00144	0.00144	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.00138	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00133	0.00133	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.00132	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.0011	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00105	0.00105	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00105	0.00105	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00095	0.00095	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00095	0.00095	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000934	0.000934	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000869	0.000869	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000848	0.000848	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000759	0.000759	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000758	0.000758	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000758	0.000758	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000746	0.000746	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000723	0.000723	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000693	0.000693	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000606	0.000606	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000585	0.000585	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000585	0.000585	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000577	0.000577	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000576	0.000576	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000575	0.000575	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000571	0.000571	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000535	0.000535	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000468	0.000468	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000459	0.000459	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000456	0.000456	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000452	0.000452	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000445	0.000445	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000442	0.000442	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000354	0.000354	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000352	0.000352	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000247	0.000247	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000197	0.000197	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000152	0.000152	CbGpPWpGaD
